Literature DB >> 18640975

Antithrombin-binding octasaccharides and role of extensions of the active pentasaccharide sequence in the specificity and strength of interaction. Evidence for very high affinity induced by an unusual glucuronic acid residue.

Marco Guerrini1, Sara Guglieri, Benito Casu, Giangiacomo Torri, Pierre Mourier, Christian Boudier, Christian Viskov.   

Abstract

The antithrombotic activity of low molecular weight heparins (LMWHs) is largely associated with the antithrombin (AT)-binding pentasaccharide sequence AGA(*)IA (GlcN(NAc/NS,6S)-GlcA-GlcN(NS,3,6S)-IdoUA(2S)-GlcN(NS,6S)). The location of the AGA(*)IA sequences along the LMWH chains is also expected to influence binding to AT. This study was aimed at investigating the role of the structure and molecular conformation of different disaccharide extensions on both sides of the AGA(*)IA sequence in modulating the affinity for AT. Four high purity octasaccharides isolated by size exclusion chromatography, high pressure liquid chromatography, and AT-affinity chromatography from the LMWH enoxaparin were selected for the study. All the four octasaccharides terminate at their nonreducing end with 4,5-unsaturated uronic acid residues (DeltaU). In two octasaccharides, AGA(*)IA was elongated at the reducing end by units IdoUA(2S)-GlcN(NS,6S) (OCTA-1) or IdoUA-GlcN(NAc,6S) (OCTA-2). In the other two octasaccharides (OCTA-3 and OCTA-4), AGA(*)IA was elongated at the nonreducing side by units GlcN(NS,6S)-IdoUA and GlcN(NS,6S)-GlcA, respectively. Extensions increased the affinity for AT of octasaccharides with respect to pentasaccharide AGA(*)IA, as also confirmed by fluorescence titration. Two-dimensional NMR and docking studies clearly indicated that, although elongation of the AGA(*)IA sequence does not substantially modify the bound conformation of the AGA(*)IA segment, extensions promote additional contacts with the protein. It should be noted that, as not previously reported, the unusual GlcA residue that precedes the AGA(*)IA sequence in OCTA-4 induced an unexpected 1 order of magnitude increase in the affinity to AT with respect to its IdoUA-containing homolog OCTA-3. Such a residue was found to orientate its two hydroxyl groups at close distance to residues of the protein. Besides the well established ionic interactions, nonionic interactions may thus contribute to strengthen oligosaccharide-AT complexes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18640975      PMCID: PMC3258914          DOI: 10.1074/jbc.M801102200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

Review 1.  Structural characterization of low molecular weight heparins.

Authors:  B Casu; G Torri
Journal:  Semin Thromb Hemost       Date:  1999       Impact factor: 4.180

Review 2.  Structure and biological interactions of heparin and heparan sulfate.

Authors:  B Casu; U Lindahl
Journal:  Adv Carbohydr Chem Biochem       Date:  2001       Impact factor: 12.200

3.  Ion effects on ligand-nucleic acid interactions.

Authors:  M T Record; M L Lohman; P De Haseth
Journal:  J Mol Biol       Date:  1976-10-25       Impact factor: 5.469

4.  Anticoagulant activity of heparin: separation of high-activity and low-activity heparin species by affinity chromatography on immobilized antithrombin.

Authors:  M Höök; I Björk; J Hopwood; U Lindahl
Journal:  FEBS Lett       Date:  1976-07-01       Impact factor: 4.124

5.  Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor.

Authors:  M Mayer; B Meyer
Journal:  J Am Chem Soc       Date:  2001-06-27       Impact factor: 15.419

Review 6.  Production and chemical processing of low molecular weight heparins.

Authors:  R J Linhardt; N S Gunay
Journal:  Semin Thromb Hemost       Date:  1999       Impact factor: 4.180

7.  The reaction of serpins with proteinases involves important enthalpy changes.

Authors:  C Boudier; J G Bieth
Journal:  Biochemistry       Date:  2001-08-21       Impact factor: 3.162

8.  The effect of a reducing-end extension on pentasaccharide binding by antithrombin.

Authors:  K J Belzar; T R Dafforn; M Petitou; R W Carrell; J A Huntington
Journal:  J Biol Chem       Date:  2000-03-24       Impact factor: 5.157

9.  Conformation of heparin pentasaccharide bound to antithrombin III.

Authors:  M Hricovíni; M Guerrini; A Bisio; G Torri; M Petitou; B Casu
Journal:  Biochem J       Date:  2001-10-15       Impact factor: 3.857

10.  Antithrombin binding of low molecular weight heparins and inhibition of factor Xa.

Authors:  P Lin; U Sinha; A Betz
Journal:  Biochim Biophys Acta       Date:  2001-04-03
View more
  23 in total

1.  Insights into the role of 3-O-sulfotransferase in heparan sulfate biosynthesis.

Authors:  Maria Cecília Zorél Meneghetti; Tarsis Gesteira Ferreira; Alexandre Keiji Tashima; Suely F Chavante; Edwin Alexander Yates; Jian Liu; Helena Bonciani Nader; Marcelo A Lima
Journal:  Org Biomol Chem       Date:  2017-08-16       Impact factor: 3.876

2.  Antithrombin-binding oligosaccharides: structural diversities in a unique function?

Authors:  Marco Guerrini; Pierre A J Mourier; Giangiacomo Torri; Christian Viskov
Journal:  Glycoconj J       Date:  2014-10       Impact factor: 2.916

3.  Recognition and Conformational Properties of an Alternative Antithrombin Binding Sequence Obtained by Chemoenzymatic Synthesis.

Authors:  Eduardo Stancanelli; Stefano Elli; Po-Hung Hsieh; Jian Liu; Marco Guerrini
Journal:  Chembiochem       Date:  2018-03-24       Impact factor: 3.164

4.  De Novo Sequencing of Complex Mixtures of Heparan Sulfate Oligosaccharides.

Authors:  Rongrong Huang; Chengli Zong; Andre Venot; Yulun Chiu; Dandan Zhou; Geert-Jan Boons; Joshua S Sharp
Journal:  Anal Chem       Date:  2016-04-27       Impact factor: 6.986

5.  Chemoenzymatic synthesis and structural characterization of 2-O-sulfated glucuronic acid-containing heparan sulfate hexasaccharides.

Authors:  Po-Hung Hsieh; Yongmei Xu; David A Keire; Jian Liu
Journal:  Glycobiology       Date:  2014-04-25       Impact factor: 4.313

6.  Characterizing the microstructure of heparin and heparan sulfate using N-sulfoglucosamine 1H and 15N NMR chemical shift analysis.

Authors:  Derek J Langeslay; Consuelo N Beecher; Annamaria Naggi; Marco Guerrini; Giangiacomo Torri; Cynthia K Larive
Journal:  Anal Chem       Date:  2012-12-31       Impact factor: 6.986

Review 7.  Heparan sulfate and heparin interactions with proteins.

Authors:  Maria C Z Meneghetti; Ashley J Hughes; Timothy R Rudd; Helena B Nader; Andrew K Powell; Edwin A Yates; Marcelo A Lima
Journal:  J R Soc Interface       Date:  2015-09-06       Impact factor: 4.118

8.  Heparan sulfate phage display antibodies identify distinct epitopes with complex binding characteristics: insights into protein binding specificities.

Authors:  Sophie M Thompson; David G Fernig; Edwin C Jesudason; Paul D Losty; Els M A van de Westerlo; Toin H van Kuppevelt; Jeremy E Turnbull
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

Review 9.  Bioinformatics and molecular modeling in glycobiology.

Authors:  Martin Frank; Siegfried Schloissnig
Journal:  Cell Mol Life Sci       Date:  2010-04-04       Impact factor: 9.261

Review 10.  Heparan sulfate 3-O-sulfation: a rare modification in search of a function.

Authors:  Bryan E Thacker; Ding Xu; Roger Lawrence; Jeffrey D Esko
Journal:  Matrix Biol       Date:  2013-12-19       Impact factor: 11.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.